Associated Papers
Growth-inhibitory and antiangiogenic activity of the MEK inhibitor PD0325901 in malignant melanoma with or without BRAF mutations.
Ciuffreda L et al.
Neoplasia (new York, N.y.), 2009
Select a paper to view details
Ciuffreda L et al.
Neoplasia (new York, N.y.), 2009